Telomerase activity in ductal carcinoma in situ of the breast

Breast Cancer Research and Treatment

Volumn 58, Issue 1, 1999, Pages 65-69

  Shpitz, B ^a   Zimlichman, S ^a   Zemer, R ^a   Bomstein, Y ^a   Zehavi, T ^a   Liverant, S ^a   Bernehim, J ^a   Kaufman, Z ^a   Klein, E ^a   Shapira, Y ^a   Klein, A ^a  

^a MEIR MEDICAL CENTER   (Israel)

Author keywords

Breast; Ductal carcinoma in situ; Telomerase; Tumorigenesis

Indexed keywords

TELOMERASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST DUCT; CANCER INVASION; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; TELOMERASE;

EID: 0033462173     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006394209922     Document Type: Article

References (32)

1. 1. Weiner T, Cance WG: Molecular mechanism involved in tumorigenesis and their surgical implications. Am J Surg 176: 428-434, 1994
2. 2. Pilot HC: The molecular biology of carcinogenesis. Cancer 72 (Suppl 3): 962-970, 1993
3. 3. Bieche I, Lidereau R: Genetic alterations in breast cancer. Genes, Chrom Cancer 14: 227-251, 1995
4. 4. Lagios MD: Duct carcinoma in situ. Surg Clin N A 70: 853-871, 1990
5. 5. Welsh HG, Black WC: Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more cancer can we found. Ann Int Med 127: 1023-1028, 1997
6. 6. Perin T, Canzolieri V, Massarut S, et al.: Immunohistochemical evaluation of multiple biological markers in ductal carcinoma in situ of the breast. Eur J Cancer 32A: 1148-1155, 1996
7. 7. Marsh KL and Varley JM: Frequent alterations of cell cycle regulators in early-stage breast lesions as detected by immunohistochemistry. Br J Cancer 77: 1460-1468, 1998
8. 8. Bobrow LG, Happerfield LC, Gregory WM, Springhall RG, Millis RR: The classification of ductal carcinoma in situ and its association with biological markers. Semin Diagnost Pathol 11: 199-207, 1994
9. 9. Mack L, Kerkvliet N, Doig G, et al.: Relationship of a new histological cathegorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erbB-2, bcl-2 and Ki-67. Hum Pathol 28: 947-979, 1997
10. 10. Kyo S, Takakura M, Tanaka M, et al.: Quantitative differences in telomerase activity among malignant, premalignant and benign ovarian lesions. Clin Cancer Res 4: 399-405, 1998
11. 11. Cheng AJ, Tang R, Wang JY, See LC, Wang TC: Possible role of telomerase activation in the cancer predisposition of patients with hereditary non-polyposis colorectal cancers. J Natl Cancer Inst 90: 316-321, 1998
12. 12. Wisman GB, Hollema H, de Long S, et al.: Telomerase activity as biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smears. J Clin Oncol 16: 2238-2245, 1998
13. 13. Hiyama E, Hiyama K, Shay JW, Yokoyama T: Telomerase activity and expression of its components in human neuroblastoma. Proc Am Assoc Cancer Res 39: 570, 1998
14. 14. Yashima K, Ashfaq R, Nowak J, et al.: Telomerase activity and expression of its RNA component in cervical lesions. Cancer 82: 1319-1327, 1998
15. 15. Zhang W, Kapusta LR, Slingerland JM, Klotz LH: Telomerase activity in prostate cancer, prostatic intraepithelial hyperplasia, and benign prostatic epithelium. Cancer Res 58: 619-921, 1998
16. 16. Zakian VA: Telomeres: beginning to understand the end. Science 270: 1601-1607, 1995
17. 17. Greider CW, Blackburn EH: A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337: 331-337, 1989
18. 18. Kim NW, Piatyszek MA, Prowse KR, et al.: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994
19. 19. Rhyu MS: Telomeres, telomerases and immortality. J Natl Cancer Inst 87: 884-894, 1995
20. 20. Greider CW: Telomerase activity, cell proliferation and cancer. Proc Natl Acad Sci USA 95: 90-92, 1998
21. 21. Write WE, Shay JW: Telomere positional effects and the regulation of cellular senescence. Trends Genet 8: 193-197, 1992
22. 22. Shay JW, Bacchetti S: A survey of telomerase in human cancer. Eur J Cancer 33: 787-791, 1997
23. 23. Shay JW, Gazdar AF: Telomerase in the early detection of cancer. J Clin Pathol 50: 106-109, 1997
24. 24. Breslow RA, Shay JW, Gazdar AF, Srivastava S: Telomerase and early detection of cancer: a national cancer institute workshop. J Natl Cancer Inst 89: 618-623, 1997
25. 25. Hiyama E, Gollahon LS, Kataoka T, et al.: Telomerase activity in human breast tumors. J Natl Cancer Inst 88: 116-122, 1996
26. 26. Bednarek AK, Sahin A, Brenner AJ, Johnston DA, Aldaz CM: Analysis of telomerase activity levels in breast cancer: positive detection in the in situ breast carcinoma stage. Clin Cancer Res 3: 11-16. 1997
27. 27. Yashima K, Milchgrub S, Gollahon LS, et al.: Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast cancer. Clin Cancer Res 4: 229-234, 1998
28. 28. Devilee P, Cornellisse C: Somatic genetic changes in human breast cancer. Biochim Biophys Acta 1198: 113-130, 1994
29. 29. Umbricht CB, Sherman M, Dome J, Adey C, Kim N, Sukumar S: Telomerase activity in preinvasive breast cancer. Proc Am Assoc Cancer Res 39: 543, 1998
30. 30. Klingelhutz AJ: Telomerase activation and cancer. J Mol Med 75: 45-49, 1997
31. 31. Belair CD, Yager TR, Lopez PM, Reznikoff CA: Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA 94: 13677-13682, 1997
32. 32. Prowse KR, Greider CW: Development and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci 92: 4818-4822, 1995